🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2014-06-17
Trial ID
NCT01926665
Treatments Being Tested
This phase I/II trial identifies the best dose and side effects of selinexo...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-05-06
Trial ID
NCT04764942
This study evaluates the safety, tolerability, pharmacokinetics, and effica...
Status
Terminated
Location
Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW)
Start Date
2017-12-14
Trial ID
NCT03341767
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
BEAT Tuberculosis is a phase 3, open label, multi-centre, randomized contro...
Status
Completed
Location
Jose Pearson TB Hospital
Start Date
2019-08-22
Trial ID
NCT04062201
The purpose of the study was to evaluate the efficacy (how well the medicin...
Status
Completed
Location
Gaborone CRS (Site ID: 12701)
Start Date
2022-09-27
Trial ID
NCT05007821
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
This phase I trial tests the safety, side effects, and best dose of carfilz...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-04-24
Trial ID
NCT06249282
This is a multicenter, open-label, dose escalation Phase 1 study....
Status
Completed
Location
RMCC
Start Date
2010-08
Trial ID
NCT01204164
Treatments Being Tested
Clofazimine (CFZ) is a promising drug for the treatment of NTM diseases. CF...
Status
Completed
Location
Radboud university medical center
Start Date
2022-02-14
Trial ID
NCT05294146
Treatments Being Tested